Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Accumulated Expenses (2016 - 2026)

Healthequity has reported Accumulated Expenses over the past 13 years, most recently at $74.4 million for Q1 2026.

  • For Q1 2026, Accumulated Expenses rose 7.3% year-over-year to $74.4 million; the TTM value through Jan 2026 reached $74.4 million, up 7.3%, while the annual FY2026 figure was $74.4 million, 7.3% up from the prior year.
  • Accumulated Expenses for Q1 2026 was $74.4 million at Healthequity, up from $47.4 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $74.4 million in Q1 2026 and troughed at $20.0 million in Q2 2023.
  • A 5-year average of $45.0 million and a median of $46.0 million in 2024 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: crashed 58.19% in 2023 and later surged 74.1% in 2025.
  • Year by year, Accumulated Expenses stood at $35.1 million in 2022, then grew by 19.07% to $41.8 million in 2023, then grew by 13.56% to $47.5 million in 2024, then fell by 0.21% to $47.4 million in 2025, then soared by 56.89% to $74.4 million in 2026.
  • Business Quant data shows Accumulated Expenses for HQY at $74.4 million in Q1 2026, $47.4 million in Q4 2025, and $64.5 million in Q3 2025.